| 000 | 01902 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516194057.0 | ||
| 264 | 0 | _c20140909 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1879-2472 | ||
| 024 | 7 |
_a10.1016/j.thromres.2013.09.026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLecumberri, R | |
| 245 | 0 | 0 |
_aAdjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study. _h[electronic resource] |
| 260 |
_bThrombosis research _c2013 |
||
| 300 |
_a666-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xdrug therapy |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSmall Cell Lung Carcinoma _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLópez Vivanco, G | |
| 700 | 1 | _aFont, A | |
| 700 | 1 | _aGonzález Billalabeitia, E | |
| 700 | 1 | _aGúrpide, A | |
| 700 | 1 | _aGómez Codina, J | |
| 700 | 1 | _aIsla, D | |
| 700 | 1 | _aGalán, A | |
| 700 | 1 | _aBover, I | |
| 700 | 1 | _aDomine, M | |
| 700 | 1 | _aVicente, V | |
| 700 | 1 | _aRosell, R | |
| 700 | 1 | _aRocha, E | |
| 773 | 0 |
_tThrombosis research _gvol. 132 _gno. 6 _gp. 666-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.thromres.2013.09.026 _zAvailable from publisher's website |
| 999 |
_c23511260 _d23511260 |
||